Es-Is Technologies

Enzymatic Solutions for Drug Synthesis

Health Tech & Life Sciences
Non Active, Aug 2018
Mature Hibat Tzion Founded 2010
Total raised
Stage
Mature
Founded
2010
Headcount
6
HQ
Hibat Tzion
Sector
Health Tech & Life Sciences

About

Es-Is Technologies was created to harness the power of computing for developing enzyme-catalyzed processes more quickly and cost-effectively. The company develops novel, enzyme-based syntheses for the production of pharmaceutical ingredients. Utilizing the latest developments in computer algorithms and an understanding of biomolecules at the atomic level, Es-Is designs enzymes for the creation of synthetic chemicals via cost-effective, non-infringing, and patentable processes. Es-is works with leading pharmaceutical companies to facilitate the introduction of clean chemo-enzymatic processes instead of the purely chemical production of drugs, which consumes excess resources and increases pollution.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary focus of Es-Is Technologies?
Es-Is Technologies focuses on developing novel, enzyme-based syntheses for the production of pharmaceutical ingredients, aiming for more quick and cost-effective enzyme-catalyzed processes.
When was Es-Is Technologies founded?
Es-Is Technologies was founded in January 2010.
What is the current operational status of Es-Is Technologies?
Es-Is Technologies is currently inactive, as of August 2018.
How many employees does Es-Is Technologies have?
Es-Is Technologies has 6 employees.
Which markets does Es-Is Technologies target geographically?
Es-Is Technologies targets geographic markets including India, Spain, Europe, and China.
Who is a founder of Es-Is Technologies?
Ehud Wizer is a founder of Es-Is Technologies.
What is the primary sector of Es-Is Technologies?
The primary sector of Es-Is Technologies is Health Tech & Life Sciences.
What is the name of a product developed by Es-Is Technologies?
Es-Is Technologies developed a product called EnzyMatrix.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

pharma-companieslaboratoriesdrug-discovery